Search

Ken Hoang

Examiner (ID: 2753, Phone: (571)272-8401 , Office: P/2168 )

Most Active Art Unit
2168
Art Unit(s)
2168
Total Applications
440
Issued Applications
294
Pending Applications
50
Abandoned Applications
103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20777902 [patent_doc_number] => 20260166095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-18 [patent_title] => COMPOSITIONS FOR TREATMENT OF GLIOMA AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/531468 [patent_app_country] => US [patent_app_date] => 2026-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19588 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19531468 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/531468
COMPOSITIONS FOR TREATMENT OF GLIOMA AND USES THEREOF Feb 4, 2026 Pending
Array ( [id] => 20193824 [patent_doc_number] => 20250270534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => SYSTEM FOR INDUCING MUTATION BASED ON OPTIMIZED ACTIVATION-INDUCED CYTIDINE DEAMINASE [patent_app_type] => utility [patent_app_number] => 19/205994 [patent_app_country] => US [patent_app_date] => 2025-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19205994 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/205994
System for inducing mutation based on optimized activation-induced cytidine deaminase May 11, 2025 Issued
Array ( [id] => 20227349 [patent_doc_number] => 12415992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-16 [patent_title] => Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid [patent_app_type] => utility [patent_app_number] => 19/027003 [patent_app_country] => US [patent_app_date] => 2025-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 2039 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19027003 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/027003
Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid Jan 16, 2025 Issued
Array ( [id] => 20025144 [patent_doc_number] => 20250163366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => LIGILACTOBACILLUS ANIMALIS STRAIN AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/028457 [patent_app_country] => US [patent_app_date] => 2025-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028457 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/028457
LIGILACTOBACILLUS ANIMALIS STRAIN AND USE THEREOF Jan 16, 2025 Abandoned
Array ( [id] => 20578482 [patent_doc_number] => 12570724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Preparation method for biosynthesis of human body structural material [patent_app_type] => utility [patent_app_number] => 19/005323 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 3097 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005323 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/005323
Preparation method for biosynthesis of human body structural material Dec 29, 2024 Issued
Array ( [id] => 19800568 [patent_doc_number] => 20250066493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA [patent_app_type] => utility [patent_app_number] => 18/942174 [patent_app_country] => US [patent_app_date] => 2024-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25660 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18942174 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/942174
Production of proteins in glutamine-free cell culture media Nov 7, 2024 Issued
Array ( [id] => 19998702 [patent_doc_number] => 20250136924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => FOOD GRADE BACTERIA AND METHODS FOR REMOVING GLYPHOSATE AND OTHER HARMFUL SUBSTANCES [patent_app_type] => utility [patent_app_number] => 18/928580 [patent_app_country] => US [patent_app_date] => 2024-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18928580 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/928580
FOOD GRADE BACTERIA AND METHODS FOR REMOVING GLYPHOSATE AND OTHER HARMFUL SUBSTANCES Oct 27, 2024 Pending
Array ( [id] => 19985046 [patent_doc_number] => 20250123268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => COMPOSITIONS AND METHODS FOR ACCELERATING DEVELOPMENT OF CANCER THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 18/917986 [patent_app_country] => US [patent_app_date] => 2024-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38357 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18917986 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/917986
COMPOSITIONS AND METHODS FOR ACCELERATING DEVELOPMENT OF CANCER THERAPEUTICS Oct 15, 2024 Abandoned
Array ( [id] => 19998483 [patent_doc_number] => 20250136705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA [patent_app_type] => utility [patent_app_number] => 18/820925 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21135 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18820925 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/820925
PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA Aug 29, 2024 Pending
Array ( [id] => 19832344 [patent_doc_number] => 20250084130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => ENGINEERED MCP AND PCP PROTEINS AND SYSTEMS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 18/813643 [patent_app_country] => US [patent_app_date] => 2024-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18813643 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/813643
Engineered MCP and PCP proteins and systems and methods thereof Aug 22, 2024 Issued
Array ( [id] => 20444013 [patent_doc_number] => 20260000727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-01 [patent_title] => METHOD FOR VALORIZATION OF RICE HUSK [patent_app_type] => utility [patent_app_number] => 18/754426 [patent_app_country] => US [patent_app_date] => 2024-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18754426 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/754426
METHOD FOR VALORIZATION OF RICE HUSK Jun 25, 2024 Pending
Array ( [id] => 19641247 [patent_doc_number] => 20240415767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => Tattoo Aftercare Sealant Gel [patent_app_type] => utility [patent_app_number] => 18/742931 [patent_app_country] => US [patent_app_date] => 2024-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18742931 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/742931
Tattoo Aftercare Sealant Gel Jun 12, 2024 Pending
Array ( [id] => 19745949 [patent_doc_number] => 20250034514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => LACTIPLANTIBACILLUS PLANTARUM EL6 FOR INCREASING FLAVONOID CONTENT, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/665356 [patent_app_country] => US [patent_app_date] => 2024-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665356 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/665356
LACTIPLANTIBACILLUS PLANTARUM EL6 FOR INCREASING FLAVONOID CONTENT, AND USE THEREOF May 14, 2024 Abandoned
Array ( [id] => 19543395 [patent_doc_number] => 20240360431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => ENGINEERED ALPHA-GALACTOSIDASE A (A-GAL A) PEPTIDES AND FUNCTIONAL VARIANTS THEREOF AND ASSOCIATED METHODS OF TREATING FABRY DISEASE [patent_app_type] => utility [patent_app_number] => 18/649917 [patent_app_country] => US [patent_app_date] => 2024-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18649917 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/649917
ENGINEERED ALPHA-GALACTOSIDASE A (A-GAL A) PEPTIDES AND FUNCTIONAL VARIANTS THEREOF AND ASSOCIATED METHODS OF TREATING FABRY DISEASE Apr 28, 2024 Pending
Array ( [id] => 19432534 [patent_doc_number] => 20240301032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => SUBSTRATES COMPRISING ELASTIN-LIKE POLYPEPTIDES AND CALCIUM IONS [patent_app_type] => utility [patent_app_number] => 18/434379 [patent_app_country] => US [patent_app_date] => 2024-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434379 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/434379
SUBSTRATES COMPRISING ELASTIN-LIKE POLYPEPTIDES AND CALCIUM IONS Feb 5, 2024 Pending
Array ( [id] => 19380954 [patent_doc_number] => 20240270824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => HEMOGLOBIN (Hb) RECOMBINANT EXPRESSION VECTOR AND RECOMBINANT ENGINEERING BACTERIUM, AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/405405 [patent_app_country] => US [patent_app_date] => 2024-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405405 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/405405
HEMOGLOBIN (Hb) RECOMBINANT EXPRESSION VECTOR AND RECOMBINANT ENGINEERING BACTERIUM, AND PREPARATION METHOD AND USE THEREOF Jan 4, 2024 Pending
Array ( [id] => 19265710 [patent_doc_number] => 20240209409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => Method for Secretory Production of Unnatural-Amino-Acid-Containing Protein [patent_app_type] => utility [patent_app_number] => 18/401960 [patent_app_country] => US [patent_app_date] => 2024-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18401960 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/401960
Method for Secretory Production of Unnatural-Amino-Acid-Containing Protein Jan 1, 2024 Pending
Array ( [id] => 19389460 [patent_doc_number] => 20240279330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => ERYTHROCYTE-BINDING THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 18/542152 [patent_app_country] => US [patent_app_date] => 2023-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18542152 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/542152
ERYTHROCYTE-BINDING THERAPEUTICS Dec 14, 2023 Abandoned
Array ( [id] => 19067649 [patent_doc_number] => 20240102075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => METHOD FOR QUANTIFYING 25-HYDROXYVITAMIN D, HYDROXYLASE, QUANTIFICATION COMPOSITION, QUANTIFICATION KIT, ELECTRODE, SENSOR CHIP, AND SENSOR [patent_app_type] => utility [patent_app_number] => 18/538143 [patent_app_country] => US [patent_app_date] => 2023-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538143 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/538143
METHOD FOR QUANTIFYING 25-HYDROXYVITAMIN D, HYDROXYLASE, QUANTIFICATION COMPOSITION, QUANTIFICATION KIT, ELECTRODE, SENSOR CHIP, AND SENSOR Dec 12, 2023 Pending
Array ( [id] => 19379188 [patent_doc_number] => 20240269058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => AGAR HYDROLYSIS PRODUCT HAVING HYALURONIDASE INHIBITORY ACTIVITY AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/527564 [patent_app_country] => US [patent_app_date] => 2023-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6438 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527564 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/527564
AGAR HYDROLYSIS PRODUCT HAVING HYALURONIDASE INHIBITORY ACTIVITY AND USES THEREOF Dec 3, 2023 Pending
Menu